Innate Pharma (IPHA) Current Taxes (2019 - 2025)
Innate Pharma's (IPHA) quarterly Current Taxes came in at $37.0 million in Q4 2025, down 15.91% YoY from $43.9 million in Q4 2024, and down 5.42% on a QoQ basis from $39.1 million in Q2 2025.
Innate Pharma (IPHA) Current Taxes (2019 - 2025) Analysis & Trends
Innate Pharma (IPHA) has 7 years of Current Taxes data on file, last reported at $37.0 million in Q4 2025.
- Quarterly Current Taxes fell 15.91% year-over-year to $37.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $37.0 million (down 15.91% YoY) and the FY2025 annual result came in at $37.0 million, down 15.91% from the prior year.
- Current Taxes retreated to $37.0 million in Q4 2025, from $39.1 million in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $62.9 million in Q2 2022 to a low of $37.0 million in Q4 2025.
- A 5-year average of $46.8 million and a median of $45.7 million in 2024 frame the typical range for Current Taxes.
- Annual changes were most pronounced in 2021 — Current Taxes slumped 99.61% — and 2022, when it soared 43.22%.
- Tracing IPHA's Current Taxes over 5 years: stood at $37.7 million in 2021, then surged by 43.22% to $54.1 million in 2022, then decreased by 10.38% to $48.4 million in 2023, then fell by 9.29% to $43.9 million in 2024, then decreased by 15.91% to $37.0 million in 2025.
- The last three Current Taxes figures came in at $37.0 million (Q4 2025), $39.1 million (Q2 2025), and $43.9 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 76.32 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.36 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Innate Pharma | 202.03 Mn | 202.03 Mn | - | 36.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 36.96 Mn |
| Jun 30, 2025 | 39.07 Mn |
| Dec 31, 2024 | 43.95 Mn |
| Jun 30, 2024 | 45.12 Mn |
| Dec 31, 2023 | 48.45 Mn |
| Jun 30, 2023 | 53.92 Mn |
| Dec 31, 2022 | 54.06 Mn |
| Jun 30, 2022 | 62.91 Mn |
| Dec 31, 2021 | 37.75 Mn |
| Jun 30, 2021 | 46.30 Mn |
| Dec 31, 2020 | 53.48 Mn |
| Jun 30, 2020 | 12.01 Bn |
| Dec 31, 2019 | 23.58 Mn |